LOGO
LOGO

Zhejiang Jingxin Pharmaceutical Co., Ltd. Full Year Income Advances

By RTTNews Staff Writer   ✉   | Published:   | Follow Us On Google News

Zhejiang Jingxin Pharmaceutical Co., Ltd. (002020.SZ) released a profit for its full year that Increases, from the same period last year

The company's earnings totaled RMB757.97 million, or RMB0.92 per share. This compares with RMB711.96 million, or RMB0.83 per share, last year.

Excluding items, Zhejiang Jingxin Pharmaceutical Co., Ltd. reported adjusted earnings of RMB712.08 million or RMB0.86 per share for the period.

The company's revenue for the period fell 2.1% to RMB4.069 billion from RMB4.158 billion last year.

Zhejiang Jingxin Pharmaceutical Co., Ltd. earnings at a glance (GAAP) :

-Earnings: RMB757.97 Mln. vs. RMB711.96 Mln. last year.
-EPS: RMB0.92 vs. RMB0.83 last year.
-Revenue: RMB4.069 Bln vs. RMB4.158 Bln last year.

For comments and feedback contact: editorial@rttnews.com

Global Economics Weekly Update - April 27 – May 01, 2026

May 01, 2026 15:54 ET
Central banks dominated the economics news flow this week with almost all major ones announcing their latest policy decisions and many boosted expectations for a rate hike in June. In other news, several countries released the preliminary data for first quarter economic growth. In the U.S., comments by Fed Chair Jerome Powell were also in focus as his term ends this month.

RELATED NEWS
Latest Updates on COVID-19